Michael Ryskin
Stock Analyst at Bank of America Securities
(3.16)
# 2,436
Out of 4,377 analysts
664
Total ratings
50.1%
Success rate
1.7%
Average return
Main Sectors:
Stocks Rated by Michael Ryskin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CRL Charles River Laboratories International | Maintained: Buy | n/a | $181.34 | - | 19 | Jun 5, 2026 | |
| A Agilent Technologies | Reiterated: Buy | $145 → $155 | $135.44 | +14.44% | 24 | Jun 2, 2026 | |
| BRKR Bruker | Reiterated: Buy | $65 | $56.39 | +15.27% | 25 | Jun 2, 2026 | |
| DHR Danaher | Maintained: Buy | $270 | $184.30 | +46.50% | 38 | Jun 2, 2026 | |
| TMO Thermo Fisher Scientific | Maintained: Buy | $630 | $472.80 | +33.25% | 29 | Jun 2, 2026 | |
| WAT Waters | Reiterated: Hold | $370 → $400 | $365.36 | +9.48% | 20 | Jun 2, 2026 | |
| WST West Pharmaceutical Services | Maintained: Buy | n/a | $314.50 | - | 16 | Jun 2, 2026 | |
| ICLR ICON Public Limited Company | Reiterated: Sell | $105 → $125 | $149.45 | -16.36% | 20 | Jun 1, 2026 | |
| TEM Tempus AI | Maintained: Hold | $64 | $46.43 | +37.84% | 15 | Jun 1, 2026 | |
| ALGN Align Technology | Maintained: Sell | $175 | $167.74 | +4.33% | 24 | May 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $100 | $162.32 | -38.39% | 46 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $98.37 | - | 17 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $31.04 | - | 27 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $56 → $49 | $36.68 | +33.59% | 16 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $245 | $183.45 | +33.55% | 17 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $28 | $16.49 | +69.80% | 7 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $27 | $20.54 | +31.45% | 1 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $1,154.33 | - | 12 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | n/a | $4.57 | - | 9 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | n/a | $2.80 | - | 9 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $120 → $135 | $125.61 | +7.48% | 16 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $14.38 | - | 22 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $8 → $9.5 | $16.08 | -40.92% | 12 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $790 → $660 | $562.16 | +17.40% | 31 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $13 → $11 | $10.90 | +0.92% | 13 | Apr 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $140 | $79.44 | +76.23% | 41 | Apr 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $30 | $23.63 | +26.96% | 34 | Apr 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $225 | $200.29 | +12.34% | 15 | Apr 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $295 | $265.15 | +11.26% | 11 | Apr 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $30 → $28 | $18.46 | +51.68% | 13 | Mar 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $13 → $11 | $9.16 | +20.09% | 21 | Feb 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $32 → $38 | $32.43 | +17.18% | 13 | Feb 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $9 → $8 | $5.02 | n/a | 13 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $15 → $17 | $5.37 | n/a | 12 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $10 | $8.22 | n/a | 1 | Jul 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $10 → $2.4 | $6.40 | n/a | 3 | Apr 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $31 → $10 | $3.32 | n/a | 2 | Apr 18, 2022 |
Charles River Laboratories International
Jun 5, 2026
Maintained: Buy
Price Target: n/a
Current: $181.34
Upside: -
Agilent Technologies
Jun 2, 2026
Reiterated: Buy
Price Target: $145 → $155
Current: $135.44
Upside: +14.44%
Bruker
Jun 2, 2026
Reiterated: Buy
Price Target: $65
Current: $56.39
Upside: +15.27%
Danaher
Jun 2, 2026
Maintained: Buy
Price Target: $270
Current: $184.30
Upside: +46.50%
Thermo Fisher Scientific
Jun 2, 2026
Maintained: Buy
Price Target: $630
Current: $472.80
Upside: +33.25%
Waters
Jun 2, 2026
Reiterated: Hold
Price Target: $370 → $400
Current: $365.36
Upside: +9.48%
West Pharmaceutical Services
Jun 2, 2026
Maintained: Buy
Price Target: n/a
Current: $314.50
Upside: -
ICON Public Limited Company
Jun 1, 2026
Reiterated: Sell
Price Target: $105 → $125
Current: $149.45
Upside: -16.36%
Tempus AI
Jun 1, 2026
Maintained: Hold
Price Target: $64
Current: $46.43
Upside: +37.84%
Align Technology
May 27, 2026
Maintained: Sell
Price Target: $175
Current: $167.74
Upside: +4.33%
May 14, 2026
Maintained: Sell
Price Target: $100
Current: $162.32
Upside: -38.39%
May 14, 2026
Maintained: Hold
Price Target: n/a
Current: $98.37
Upside: -
May 14, 2026
Maintained: Hold
Price Target: n/a
Current: $31.04
Upside: -
May 13, 2026
Maintained: Buy
Price Target: $56 → $49
Current: $36.68
Upside: +33.59%
May 13, 2026
Maintained: Buy
Price Target: $245
Current: $183.45
Upside: +33.55%
May 13, 2026
Maintained: Buy
Price Target: $28
Current: $16.49
Upside: +69.80%
May 12, 2026
Initiated Coverage: Hold
Price Target: $27
Current: $20.54
Upside: +31.45%
May 11, 2026
Maintained: Buy
Price Target: n/a
Current: $1,154.33
Upside: -
May 7, 2026
Maintained: Sell
Price Target: n/a
Current: $4.57
Upside: -
May 7, 2026
Maintained: Sell
Price Target: n/a
Current: $2.80
Upside: -
May 7, 2026
Reiterated: Buy
Price Target: $120 → $135
Current: $125.61
Upside: +7.48%
May 7, 2026
Maintained: Buy
Price Target: n/a
Current: $14.38
Upside: -
May 6, 2026
Reiterated: Sell
Price Target: $8 → $9.5
Current: $16.08
Upside: -40.92%
May 5, 2026
Maintained: Hold
Price Target: $790 → $660
Current: $562.16
Upside: +17.40%
Apr 29, 2026
Maintained: Hold
Price Target: $13 → $11
Current: $10.90
Upside: +0.92%
Apr 28, 2026
Reiterated: Hold
Price Target: $140
Current: $79.44
Upside: +76.23%
Apr 28, 2026
Maintained: Buy
Price Target: $30
Current: $23.63
Upside: +26.96%
Apr 21, 2026
Maintained: Buy
Price Target: $225
Current: $200.29
Upside: +12.34%
Apr 7, 2026
Maintained: Buy
Price Target: $295
Current: $265.15
Upside: +11.26%
Mar 4, 2026
Maintained: Buy
Price Target: $30 → $28
Current: $18.46
Upside: +51.68%
Feb 11, 2026
Reiterated: Hold
Price Target: $13 → $11
Current: $9.16
Upside: +20.09%
Feb 5, 2026
Reiterated: Sell
Price Target: $32 → $38
Current: $32.43
Upside: +17.18%
Mar 3, 2025
Maintained: Buy
Price Target: $9 → $8
Current: $5.02
Upside: n/a
Feb 27, 2025
Reiterated: Buy
Price Target: $15 → $17
Current: $5.37
Upside: n/a
Jul 18, 2024
Maintained: Sell
Price Target: $10
Current: $8.22
Upside: n/a
Apr 24, 2023
Maintained: Sell
Price Target: $10 → $2.4
Current: $6.40
Upside: n/a
Apr 18, 2022
Downgraded: Hold
Price Target: $31 → $10
Current: $3.32
Upside: n/a